Entest BioMedical Inc. (OTCBB: ENTB) Obtains Specimen To Be Used In Immunotherapeutic Cancer Vaccine Research

Links shared publicly online about this topic.

  • 1,459
    total visits

Entest BioMedical Inc. (OTCBB: ENTB) Obtains Specimen To Be Used In Immunotherapeutic Cancer Vaccine Research

medicalnewstoday.com —

Entest biomedical inc. (otcbb: entb) announced it has obtained its first tumor specimen, a canine parathyroid tumor to be utilized in the development of entest's immunotherapeutic cancer vaccine.

View full resource at medicalnewstoday.com

Tags: Vaccination, Cancer, Vaccine

  • Share

Most Recently Shared on January 13, 2010 at 4:12 pm By:

mnt_cancer MNT Cancer News

Entest BioMedical Inc. (OTCBB: ENTB) Obtains Specimen To Be Used In Immunotherapeutic Cancer Vaccine Research http://mnt.to/3wcT

2 years ago...

Reply

Retweet

Favorite

Advertisement